Logo Lanfrica

Sustainability of immune response to Hepatitis B Virus vaccination 3 years post vaccination among HIV-1 infected and uninfected adults in Kenya

Créateur:
InsRos
Éditeur:
Val
Hôte:

Similaires

PO 8481 HIGH HEPATITIS B VIRUS INCIDENCE AMONG HIV-1-INFECTED TREATMENT-NAIVE ADULTS IN BOTSWANA

Background Hepatitis B virus (HBV) is one of the leading causes of death worldwi

Impact and long-term protection of hepatitis B vaccination: 17 years after universal hepatitis B vaccination in Tunisia

SUMMARY Hepatitis B virus (HBV) vaccination has been part of the Expanded Programme of Immunization

Hepatitis B Virus Sero-profiles and Genotypes in HIV-1 Infected and Uninfected Injection and Non-Injection Drug Users from Coastal Kenya

Neighbour-Joining method based on 1000 bootstrap replicates and P-distances were used for generating

Data from: Hepatitis B virus sero-profiles and genotypes in HIV-1 infected and uninfected injection and non-injection drug users from coastal Kenya

Background: Information about HBV sero-markers, infection stages and genotypes in HIV-1 infected an

Hepatitis B vaccination in Burkina Faso: prevalence of HBsAg carriage and immune response in children in the western region

Introduction: Hepatitis B virus (HBV) infection remains a major health problem in Burkina Faso. To c

Chronic hepatitis B virus coinfection is associated with renal impairment among Zambian HIV-infected adults.

Among 6789 HIV-infected Zambian adults screened for hepatitis B virus (HBV) coinfection, estimated g